DBV Technologies (DBVT) Interest Expenses (2014 - 2019)
DBV Technologies (DBVT) reported Interest Expenses of $125738.5 for Q3 2019, up 240.39% year-over-year from $36939.1 in Q3 2018, and up 28.1% on a QoQ basis from $98160.1 in Q4 2018.
DBV Technologies (DBVT) has 5 years of Interest Expenses data on file, last reported at $125738.5 in Q3 2019.
- Quarterly Interest Expenses rose 240.39% year-over-year to $125738.5 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $125738.5 (up 1362.22% YoY) and the FY2018 annual result came in at -$400630.1, up 89.77% from the prior year.
- Interest Expenses advanced to $125738.5 in Q3 2019 per DBVT's latest filing, from $98160.1 in the prior quarter.
- Across five years, Interest Expenses topped out at $125738.5 in Q3 2019 and bottomed at -$92831.9 in Q2 2015.
- The 4-year median for Interest Expenses is -$42935.3 (2016), against an average of -$285.9.
- The widest annual swing landed in 2015, when Interest Expenses plunged 162.86%; it then jumped 240.39% in 2019.
- Tracing DBVT's Interest Expenses over 4 years: stood at -$92831.9 in 2015, then soared by 53.75% to -$42935.3 in 2016, then jumped by 328.62% to $98160.1 in 2018, then climbed by 28.1% to $125738.5 in 2019.
- Per Business Quant, the three latest DBVT Interest Expenses figures stand at $125738.5 (Q3 2019), $98160.1 (Q4 2018), and -$89560.9 (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 125,738.49 |
| Sep 30, 2019 | 125,738.49 |
| Dec 31, 2018 | 98,160.09 |
| Dec 31, 2018 | 98,160.09 |
| Sep 30, 2018 | -89,560.95 |
| Sep 30, 2018 | -89,560.95 |
| Jun 30, 2016 | -42,935.25 |
| Jun 30, 2016 | -42,935.25 |
| Jun 30, 2015 | -92,831.87 |
| Jun 30, 2015 | -92,831.87 |
| Jun 30, 2014 | -35,316.09 |
| Jun 30, 2014 | -35,316.09 |